Healthequity Inc (HQY) Price Target Increased to $51.00 by Analysts at JPMorgan Chase & Co.

Healthequity Inc (NASDAQ:HQY) had its price target increased by JPMorgan Chase & Co. from $44.00 to $51.00 in a report released on Wednesday. They currently have an overweight rating on the stock.

HQY has been the topic of several other reports. Zacks Investment Research lowered shares of Healthequity from a hold rating to a sell rating in a report on Monday, December 12th. Chardan Capital reaffirmed a buy rating and issued a $47.00 price target on shares of Healthequity in a report on Tuesday, February 7th. FIX assumed coverage on shares of Healthequity in a report on Tuesday, March 14th. They issued an outperform rating on the stock. Oppenheimer Holdings Inc. began coverage on shares of Healthequity in a report on Monday, March 13th. They issued an outperform rating and a $58.00 price target on the stock. Finally, KeyCorp began coverage on shares of Healthequity in a research note on Monday, January 23rd. They set an overweight rating and a $60.00 target price on the stock. Three research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Healthequity has a consensus rating of Buy and an average target price of $44.70.

Shares of Healthequity (NASDAQ:HQY) opened at 41.28 on Wednesday. Healthequity has a 52 week low of $22.26 and a 52 week high of $49.25. The company has a market capitalization of $2.46 billion, a PE ratio of 93.82 and a beta of 1.94. The firm’s 50-day moving average price is $43.52 and its 200 day moving average price is $40.78.

Healthequity (NASDAQ:HQY) last posted its quarterly earnings results on Tuesday, March 21st. The company reported $0.07 EPS for the quarter, beating the consensus estimate of $0.04 by $0.03. Healthequity had a net margin of 15.19% and a return on equity of 11.08%. The company had revenue of $46.83 million for the quarter, compared to analyst estimates of $45.55 million. During the same period in the prior year, the company earned $0.07 earnings per share. The firm’s revenue was up 30.4% on a year-over-year basis. Equities analysts predict that Healthequity will post $0.57 EPS for the current year.

WARNING: “Healthequity Inc (HQY) Price Target Increased to $51.00 by Analysts at JPMorgan Chase & Co.” was first published by Mideast Time and is the property of of Mideast Time. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.mideasttime.com/healthequity-inc-hqy-price-target-increased-to-51-00-by-analysts-at-jpmorgan-chase-co/1590112.html.

In related news, insider Stephen Neeleman sold 1,200 shares of the firm’s stock in a transaction dated Wednesday, March 22nd. The shares were sold at an average price of $46.18, for a total value of $55,416.00. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, VP Ashley Dreier sold 5,000 shares of the firm’s stock in a transaction dated Monday, March 20th. The shares were sold at an average price of $45.80, for a total transaction of $229,000.00. Following the completion of the transaction, the vice president now directly owns 5,000 shares in the company, valued at $229,000. The disclosure for this sale can be found here. Over the last three months, insiders have sold 1,221,920 shares of company stock worth $56,457,573. Corporate insiders own 29.00% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Macquarie Group Ltd. bought a new position in shares of Healthequity during the second quarter worth $2,309,000. Capstone Asset Management Co. raised its position in shares of Healthequity by 18.5% in the third quarter. Capstone Asset Management Co. now owns 12,680 shares of the company’s stock worth $480,000 after buying an additional 1,980 shares in the last quarter. DORCHESTER WEALTH MANAGEMENT Co bought a new position in shares of Healthequity during the third quarter worth $454,000. Lebenthal Lisanti Capital Growth LLC bought a new position in shares of Healthequity during the third quarter worth $666,000. Finally, Louisiana State Employees Retirement System raised its position in shares of Healthequity by 21.0% in the third quarter. Louisiana State Employees Retirement System now owns 19,000 shares of the company’s stock worth $719,000 after buying an additional 3,300 shares in the last quarter. 89.22% of the stock is currently owned by hedge funds and other institutional investors.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

5 Day Chart for NASDAQ:HQY

Receive News & Ratings for Healthequity Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity Inc and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.